Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 623 of 6351
-
Can a cancer drug beat steroids for brain radiation injury?
Disease control Recruiting nowCerebral radiation necrosis (CRN) is a severe complication of high-dose radiation for brain metastases (BM) or glioma, which can potentially cause significant neurologic symptoms leading to serious morbidity and impaired quality of life (QoL). The first-line therapy for symptomat…
Phase 3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New pill could help regrow hair in severe alopecia
Disease control OngoingAlopecia areata (AA) is a disease that happens when the immune system attacks hair follicles and causes hair loss. AA usually affects the head and face, but hair loss can happen on any part of the body. The purpose of this study is to assess how safe, effective, and tolerable upa…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New drug aims to tame overactive thyroid without lifelong pills
Disease control Recruiting nowThis is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can a laser treat glaucoma without touching the eye?
Disease control CompletedThe purpose of this clinical trial is to determine how safe and effective (how well it works) the ELLEX TSLT device is for the treatment of Glaucoma and Ocular Hypertension using Transscleral Selective Laser Trabeculoplasty. Selective Laser Trabeculoplasty (SLT) is a type of las…
Sponsor: Lumibird Medical (Quantel Medical, Ellex Medical, Optotek) • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a daily pill help people with type 2 diabetes shed weight?
Disease control Stopped earlyThe main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes. Participation in the study wil…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New hope for lung cancer: targeted drug plus local therapy may delay progression
Disease control Recruiting nowThe goal of this clinical trial is to learn if the treatment by systemic Brigatinib (ALUNBRIG®) associated to local ablative therapy (LAT) treatment is improved if administered when the brigatinib works best in participants presenting an advanced non-small cells lung cancer with …
Phase 2 • Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug combo aims to boost Radiation's punch against childhood brain tumors
Disease control OngoingThis phase I clinical trial studies the side effects and best dose of AZD1390 and to see how well it works when given together with radiation therapy for the treatment of pediatric patients with high grade glioma, diffuse midline glioma or diffuse intrinsic pontine glioma. AZD139…
Phase 1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New blood test could spot 10 cancers before symptoms start
Diagnosis Recruiting nowThe Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. An MCD test measures markers in the blood in order to screen for multiple cancers simultaneously. There is a n…
Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Sep 04, 2026 00:00 UTC
-
Strength training and protein supplements may keep seniors on their feet
Disease control CompletedThis study is a five-arm, parallel-group, assessor-blinded randomized controlled trial designed to evaluate the effects of resistance-dominant multicomponent training combined with nutritional supplementation on intrinsic capacity and disability risk among rural Chinese older adu…
Sponsor: Capital University of Physical Education and Sports, China • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a simple supplement boost health for moms and babies?
Prevention Recruiting nowThe objective of this research is to understand how antenatal multiple micronutrient supplements (MMS) can be effectively implemented and scaled within the Uganda national health system context to support improved maternal nutrition and birth outcomes. Formative research has been…
Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Could your own lung cells heal damaged airways? a new trial aims to find out
Disease control Recruiting nowThis clinical trial aims to evaluate the safety and efficacy of REGEND001, an autologous basal layer stem cell transplantation therapy, in patients with chronic structural lung disease (bronchiectasis). The treatment involves harvesting bronchial basal layer stem cells from the p…
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New 'Alpha Bullets' radiation device targets tough pancreatic tumors
Disease control Recruiting nowThis is a multi-center clinical study enrolling up to 50 participants. The primary objective of the study is to evaluate the safety of Alpha DaRT in combination with chemotherapy, based on the cumulative incidence rate, severity and outcome of device related AEs. Classification o…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new injection tame overactive blood cell production?
Disease control Recruiting nowThis is a multicenter, open-label Phase I clinical trial of BEBT-507 in subjects with polycythemia vera(PV). Phase Ia is a single-agent dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), preliminary efficacy, and pharmacodynamics of BEBT-5…
Phase 1 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New shot aims to slash sky-high cholesterol in rare genetic disease
Disease control OngoingThis multicenter, randomized, placebo-controlled study will evaluate the efficacy and safety of zodasiran subcutaneous (SC) injection in subjects 12 years of age and older with genetically or clinically diagnosed Homozygous familial hypercholesterolemia (HoFH). After completion o…
Phase 3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a new antibody help the immune system fight advanced cancers?
Disease control Recruiting nowPhase 1 first-in-human, open-label, dose-escalation (3 + 3), dose-expansion clinical trial to evaluate the safety, tolerability and preliminary clinical efficacy of M3T01 (fully human IgG4/kappa monoclonal antibody targeting FasL) in subjects with metastatic or unresectable solid…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Pulsing radiation may spare esophageal cancer patients from agonizing throat pain
Symptom relief Recruiting nowThis is a prospective, randomized, open-label, two-arm phase 2 trial that will evaluate whether the use of Pulsed Low-Dose-Rate radiation technique, as compared to standard radiation, is associated with reduced rates of clinically significant esophagitis during and following chem…
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can a needle zap away chronic neck pain? three techniques put to the test
Symptom relief CompletedProspective, assessor-blinded, randomized controlled trial comparing ultrasound-guided dry needling, lidocaine injection, and oxygen-ozone injection in patients with myofascial pain syndrome (MPS) of the upper trapezius muscle. 76 participants received weekly injections/needling …
Sponsor: Derince Training and Research Hospital • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Engineered immune cells take aim at debilitating autoimmune diseases
Disease control Recruiting nowThis is an open label, single-site, dose-escalation study in up to 12 participants with relapsed or refractory Neurological Autoimmune Diseases. This study aims to evaluate the safety and efficacy of the treatment with universal CD19/BCMA CAR T-cells.
Early phase 1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Head-to-Head: which drug tames ulcerative colitis better?
Disease control OngoingUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).This study will evaluate how safe and effective risankizumab is compared to vedolizumab in treating adult participants w…
Phase 3 • Sponsor: AbbVie • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a platelet-boosting drug improve blood counts in certain blood cancers?
Disease control PausedThe purpose of this study is to evaluate if a study drug called eltrombopag can improve the blood cell counts in patients with low-risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) with mutations in TET2 gene, observe changes in the TET2 gene over ti…
Phase 2 • Sponsor: Abhay Singh, MD MPH • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC